✦ LIBER ✦
66 Tigatuzumab, a novel anti-human death receptor 5 antibody, shows synergistic efficacy against colon cancer in vitro and in vivo in combination with chemotherapy
✍ Scribed by A. Yada; Y. Ogitani; S. Ishida; K. Ichikawa; K. Fujiwara
- Book ID
- 119602749
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 42 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.